+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Methylcobalamin methycobal in chronic diabetic neuropathy a double blind clinical and electrophysiological study

Methylcobalamin methycobal in chronic diabetic neuropathy a double blind clinical and electrophysiological study

Clinical Trials Journal 23(2): 130-140

The value of administering vitamin B complex to diabetics with chronic neuropathy is dubious. We therefore investigated the active metabolite of vitamin B12 (methylcobalamin (CH3-B12); Methylcobal) given orally in large doses of 1500 .mu.g daily for three months in a double-blind study. The 42 patients selected had long-standing diabetes (mean duration 12 years) with symptoms of neuropathy. They were divided into two groups of 21 patients. Each group in turn was given either CH3-B12 or placebo. All patients were on a home glucose monitoring scheme and their blood sugar was fairly well controlled. A clinical evaluation, neuropsychological study and HbA1 estimation were done before and after treatment with the drug or placebo. Clinical evaluation included scoring on a 4-point scale for numbness, pain, cramps, weakness and impotence. The signs assessed were the deep tendon reflexes, sensory loss to pin-prick, two point discrimination and the bulbocavernosus reflex. The electrophysiological investigations carried out were the maximum motor conduction velocity (MMCV) and distal motor latency of the median, lateral popliteal and posterior tibial nerves; the H reflex; maximum sensory conduction velocity and amplitude of the media median and sural nerves; visual evoked responses; and the scalp somatosensory response (SSER) of the median nerve. Statistical analyses included the Student's paired t-test and the Wilcoxon's signed rank test. Three patients receiving placebo dropped out and the other placebo patients showed no significant change in any parameter. The 21 patients receiving CH3-B12 showed significant improvement (P < 0.01) for 2-point discrimination, pain and cramps. In addition there was improvement in the MMCV (P < 0.05) and SSER (P < 0.05) of the median nerve. No adverse effects were observed. We conclude that CH3-B12 provides satisfactory symptomatic relief and its action is due partly to improvement in motor and sensory function, possibly by promoting myelin and axonal phospholipid synthesis.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 005892018

Download citation: RISBibTeXText

Related references

Methylcobalamin in chronic diabetic neuropathy double blind clinical and electrophysiological study. Journal of Neurology 232(Suppl.): 104, 1985

Effects of acetyl-L-carnitine and methylcobalamin for diabetic peripheral neuropathy: A multicenter, randomized, double-blind, controlled trial. Journal of Diabetes Investigation 7(5): 777-785, 2016

Ischemic neuropathy and chronic diabetic neuropathy-clinical and electrophysiological comparison. European Journal of Neurology 10(Suppl. 1): 113, 2003

Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray: a double-blind placebo-controlled cross-over study. Diabetes Care 25(10): 1699-1703, 2002

Atorvastatin treatment improves diabetic polyneuropathy electrophysiological changes in non-insulin dependent diabetic patients: a double blind, randomized clinical trial. Minerva Endocrinologica 37(2): 195-200, 2012

Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind study. Biomedicine and PharmacoTherapy 49(6): 269-277, 1995

Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study. Diabetes Care 24(10): 1776-1782, 2001

Intravenous methylcobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients. Internal Medicine 38(6): 472-475, 1999

Pyridoxine and diabetic neuropathy: a double-blind controlled study. Diabetes Care 6(1): 102-103, 1983

Amitriptyline vs. pregabalin in painful diabetic neuropathy: a randomized double blind clinical trial. Diabetic Medicine 26(10): 1019-1026, 2009

Clinical usefulness of intrathecal injection of methylcobalamin in patients with diabetic neuropathy. Clinical Therapeutics 9(2): 183-192, 1987

Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy. Journal of the Association of Physicians of India 26(5): 403-406, 1978

Differences between hereditary motor and sensory neuropathy type 2 and chronic idiopathic axonal neuropathy. A clinical and electrophysiological study. Brain 120: 955-962, 1997

A double-blind placebo-controlled study of the efficacy of cerenin on diabetic neuropathy. Neurology 46(2 Suppl. ): A132, 1996

A double blind controlled study on the effect of tolrestat on diabetic autonomic neuropathy. Diabetologia 34(Suppl. 2): A152, 1991